Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but

N Maestre1, T R Tritton, G Laurent

  • 1Institut Nationale de la Santé et de la Recherche Médicale, Institut Claudius Régaud, Toulouse, France.

Cancer Research
|April 6, 2001
PubMed

Insights

Anthracyclines induce cell death, but apoptosis requires drug internalization. Membrane interaction alone triggers necrosis, not apoptosis, highlighting the importance of intracellular drug action in cancer therapy signaling.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Anthracyclines are DNA intercalators known for their cytotoxic effects.
  • The precise mechanism of anthracycline-induced cell death, particularly apoptosis, is under investigation.
  • It remains unclear if direct drug-DNA interaction is essential for initiating apoptosis signaling.

Purpose of the Study:

  • To investigate the role of anthracycline internalization in inducing apoptosis.
  • To differentiate between cellular responses to membrane-bound versus internalized anthracyclines.
  • To determine if DNA intercalation is necessary for apoptosis signaling.

Main Methods:

  • Utilized myeloid leukemia U937 cell line.
  • Compared cytotoxic effects of free daunorubicin (DNR)/doxorubicin (DOX) with immobilized DNR (iDNR)/DOX (iDOX).
  • Assessed apoptosis markers (ceramide generation, sphingomyelinase activation, PARP cleavage) and NF-κB activation.

Main Results:

  • Both free and immobilized anthracyclines exhibited cytotoxicity.
  • Only free anthracyclines induced apoptosis; immobilized drugs led to necrosis.
  • Nuclear factor-kappaB (NF-κB) activation occurred with both free and immobilized drugs, indicating membrane interaction is sufficient for this pathway.
  • Apoptosis signaling pathways were not activated by immobilized anthracyclines.

Conclusions:

  • Anthracycline internalization is essential for triggering apoptosis.
  • Membrane interaction alone can activate certain signaling pathways like NF-κB but does not induce apoptosis.
  • Cell survival pathways can be initiated independently of intracellular drug-target interactions.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...